The Future of Gut Health: Pill‑Based Sampling, IBS Trials, and Calgary’s Innovation Ecosystem
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
The Future of Gut Health: Pill‑Based Sampling, IBS Trials, and Calgary’s Innovation Ecosystem
-
Narrado por:
-
De:
Welcome to the Back to Business Podcast, where we spotlight Calgary's industry leaders and delve into the heart of entrepreneurialism in our vibrant city!
Dr. Sabina Bruehlmann is the CEO of Nimble Science, a precision medicine technology company empowering clinicians, biopharma, digestive health and food companies with access to precision GI health data leveraging novel medical technology. Nimble’s SIMBA GI Health Data Platform collects endoscopic quality intestinal fluid biopsies using a simple home kit. Previously, she co-founded Zephyr Sleep Technologies, focusing on innovative diagnostic technologies where she led the R&D team. Sabina holds a BSc in Mechanical Engineering and a PhD in Biomedical Engineering with 20 years of early-stage medical technology commercialization.
Get Connected With Sabina:
https://www.nimblesci.com/
https://www.linkedin.com/in/ sabinabruehlmann/
Visit www.calpeteclub.com for information on our next networking and membership opportunities.
- https://calpeteclub.com/
- https://twitter.com/calpeteclub
- https://www.linkedin.com/in/calgary-petroleum-club-3a5868117/
- https://www.facebook.com/calpeteclub
- https://www.youtube.com/user/calpeteclub